Scalp cooling: management option for chemotherapy-induced alopecia
Abstract
Chemotherapy is increasingly being administered as a treatment for cancer and with it are a number of possible side effects. One, which has a negative impact on a patient's quality of life and their self-esteem, is that of chemotherapy-induced alopecia (CIA). A side effect of which, for some, could be prevented by the use of scalp cooling, dependent on the regimen being administered and patient choice. This article explores the issue of CIA from the patient's perspective and scalp cooling as a preventative measure, along with a review of the evidence around the risk associated with developing scalp metastases following scalp cooling. It also discusses why scalp cooling should be available for both male and female patients; along with the potential impact scalp cooling may have on clinical areas delivering chemotherapy.
References
- (2010) The effectiveness of a scalp cooling cap in preventing chemotherapy-induced alopecia. Tumori 96(2): 271–5 Crossref, Medline, Google Scholar
- (2013) Efficacy and tolerability of two scalp cooling systems for the prevention of alopecia associated with docetaxel treatment Support Care Cancer. 21(9): 2565-73 doi: https://doi.org/10.1007/s00520-013-1804-9 Crossref, Medline, Google Scholar
- (2011) Presentation, impact and prevention of chemotherapy-induced hair loss: scalp cooling potentials and limitations. Expert Review of Dermatology 6(1)109-25 doi: https://doi.org/10.1586/edm.10.76 Crossref, Google Scholar
- (2013) A comparison of men and women's experiences of chemotherapy-induced alopecia. Eur J Oncol Nurs 17(3): 255-60 doi: https://doi.org/10.1016/j.ejon.2012.06.003 Crossref, Medline, Google Scholar
- (2014) The role of scalp cooling in the prevention of Chemotherapy Induced Alopecia. European Journal of Clinical and Medical Oncology Special Edition : 65–9 Google Scholar
Department of Health (2007) Cancer Reform Strategy. Department of Health. London http://tinyurl.com/olh5z6h (accessed 28 August 2014 ) Google ScholarDignitana (2010) Summary of clinical evidence concerning the Dignicap system. Dignitana. Lund, Sweden Google Scholar- (2012) Perception, attitudes, preparedness and experience of chemotherapy-induced alopecia among breast cancer patients: a qualitative study. Asian Pac J of Cancer Prev 13(14): 1383–8 Crossref, Medline, Google Scholar
- (2013) Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia. Oncologist 18(7): 885-91 doi: https://doi.org/10.1634/theoncologist.2012-0332 Crossref, Medline, Google Scholar
- (2011) Breast cancer scalp metastasis as first metastatic site after scalp cooling: two cases of occurrence after 7- and 9-year follow-up. Breast Cancer Res Treat 128(2): 563-6 doi: https://doi.org/10.1007/s10549-011-1453-y Crossref, Medline, Google Scholar
Mynewhair (2014) I am losing my hair http://tinyurl.com/kufnwvj (accessed 28 August 2014 ) Google ScholarNational Health Service (NHS) England (2014) Waiting Times for Suspected and Diagnosed Cancer Patients: Annual Report 2013-2014. http://tinyurl.com/qzswooz (accessed 28 August 2014 ) Google Scholar- (2013) Pathobiology of chemotherapy-induced hair loss. Lancet Oncol. 14(2): e50-9 doi: https://doi.org/10.1016/S1470-2045(12)70553-3 Crossref, Medline, Google Scholar
Paxman (2014) Paxman™ Delivery Pack Issue 4. Paxman, Huddersfield Google ScholarPaxman (2013) Orbis 1 scalp cooler. Instructions for use. Issue 3. Paxman, Huddersfield Google ScholarPaxman (2012) Orbis hair loss prevention system helping to relieve the visible trauma of cancer. Paxman, Huddersfield. http://tinyurl.com/n3ahr6k (accessed 28 August 2014 ) Google Scholar- (2011) Chemotherapy-induced alopecia: advice and support for hair loss. Br J Nurs 20(10): S4-11 Link, Google Scholar
- (2011) Tumour metastasis: molecular insights and evolving paradigms. Cell 147(2): 275-92 doi: https://doi.org/10.1016/j.cell.2011.09.024. Crossref, Medline, Google Scholar
- (2012) Scalp cooling for hair preservation and associated characteristics on 1411 chemotherapy patients–results of the Dutch Scalp Cooling Registry. Acta Oncologica 00: 1–8 Google Scholar
- (2013a) Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer. Eur J Oncol Nurs 17(5): 536-40 doi: https://doi.org/10.1016/j.ejon.2013.02.004 Crossref, Medline, Google Scholar
- (2013b) Scalp cooling to prevent alopecia after chemotherapy can be considered safe in patients with breast cancer. Breast 22(5): 1001-4 doi: https://doi.org/10.1016/j.breast.2013.07.039 Crossref, Medline, Google Scholar
- (2014) Cost-effectiveness analysis of scalp cooling to reduce chemotherapy-induced alopecia. Acta Oncol 53 (1):80-7 doi: https://doi.org/10.3109/0284186X.2013.794955 Crossref, Medline, Google Scholar



